November 06, 2024 10:06 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Union Minister HD Kumaraswamy booked for threatening cop probing into mining case | Supreme Court upholds validity of Uttar Pradesh Madrasa Education Act | Not all private properties are community resources that govt can take over: Supreme Court | Pakistan's Lahore has become world's most polluted city with an AQI of 1900 on Sunday | Indian Army 'successfully completes' patrolling to a key point in Ladakh's Depsang region
India develops cost-effective handheld X-ray for TB screening
Handheld X-ray
Representational image by Anna Shvets on Pexels

India develops cost-effective handheld X-ray for TB screening

| @indiablooms | 19 Oct 2024, 01:24 pm

New Delhi/IBNS: India has made a major advancement in tuberculosis (TB) diagnostics with the creation of a homegrown portable X-ray device, according to ANI.

Developed through a partnership between IIT Kanpur and the Indian Council of Medical Research (ICMR), this new device aims to boost early TB detection by providing a more affordable alternative to imported equipment.

The device costs less than half the price of international models and is designed to improve access to TB screenings, particularly for underserved communities, by offering portable and convenient testing options near patients' homes.

ICMR Director General Rajiv Bahl highlighted this innovation during the 19th International Conference of Drug Regulatory Authorities (ICDRA) INDIA-2024.

He emphasized that this new technology could have a significant impact on public health in India by enabling more widespread and timely diagnosis and treatment of TB.

Bahl also announced the creation of three Mpox testing kits, currently being produced by three different companies, as part of the country’s ongoing healthcare advancements.

The fight against sickle cell disease was another focus. India, with over a million affected individuals, has the world's second-largest population of sickle cell patients.

The ICMR Director General revealed that 18 new, low-cost tests for detecting sickle cell anemia have been developed, bringing down the cost from Rs 400 to just Rs 30 per test, making screening far more affordable.

This development aligns with the National Sickle Cell Anaemia Elimination Mission, launched by Prime Minister Narendra Modi last year, which aims to eradicate the disease as a public health issue by 2047.

In other health news, India is in the third phase of clinical trials for a dengue vaccine, according to reports.

Bahl expressed hope for positive results within a year.

If proven safe and effective, the vaccine could become a critical asset in the country’s efforts to control dengue.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.